The Impact of COVID-19 on Medical-related American Stocks
Lists
Only you see this
Abstract
Since the outbreak of COVID-19 in 2020, there has been a very serious impact on the global economy. In this paper, the period from May 2019 to February 2020 was selected as the pre-epidemic, and the period from March to December 2020 was selected as the mid-epidemic. The stocks of the US healthcare sector are analyzed in these two time periods, respectively. Fama-French five-factor model is used to analyze the risks and returns of investing in the Health, Drugs, and Medical Equipment sectors. Based on the data obtained from multiple linear regressions, it was concluded that all healthcare-related sectors were affected by the epidemic to varying degrees. Some of the significant factors became insignificant in both the healthcare and medical equipment sectors. At the same time, smaller companies in the drugs industry were also affected to a greater extent than larger ones, and the vulnerability reflected in the pandemic also gave a significant impetus to the overall medical-related industries.
BibTeX
@inproceedings{wei2022impact,
author = {Tongke Wei and Yuheng Wu and Xiaoyu Yang},
title = {{The Impact of COVID-19 on Medical-related American Stocks}},
booktitle = {Advances},
year = {2022},
doi = {10.2991/aebmr.k.220307.334},
}